XML 31 R16.htm IDEA: XBRL DOCUMENT v3.6.0.2
Note 8 - Income Taxes
12 Months Ended
Dec. 03, 2016
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
Note
8:
Income Taxes
 
Income from continuing operations before income taxes and income from equity method investments
 
 
2016
 
 
2015
 
 
2014
 
United States
 
$
76,199
 
  $
97,094
    $
55,567
 
Non-U.S.
 
 
91,226
 
   
41,251
     
23,745
 
Total
 
$
167,425
 
  $
138,345
    $
79,312
 
 
Components of the provision for income tax expense (benefit)
 
2016
 
 
2015
 
 
2014
 
Current:
                       
U.S. federal
 
$
14,515
 
  $
24,180
    $
8,771
 
State
 
 
2,789
 
   
2,955
     
1,290
 
Non-U.S.
 
 
27,788
 
   
22,075
     
20,133
 
 
 
 
45,092
 
   
49,210
     
30,194
 
Deferred:
                       
U.S. federal
 
 
6,444
 
   
8,096
     
8,106
 
State
 
 
1,102
 
   
1,269
     
1,069
 
Non-U.S.
 
 
(2,202
)
   
(2,720
)    
(5,021
)
 
 
 
5,344
 
   
6,645
     
4,154
 
Total
 
$
50,436
 
  $
55,855
    $
34,348
 
 
 
Reconciliation of effective income tax
 
2016
 
 
2015
 
 
2014
 
Statutory U.S. federal income tax rate
 
$
58,599
 
  $
48,421
    $
27,759
 
State income taxes, net of federal benefit
 
 
2,135
 
   
3,281
     
1,534
 
Foreign dividend repatriation
 
 
519
 
   
388
     
760
 
Foreign operations
 
 
(3,386
)
   
1,547
     
(8,287
)
Impact of option valuation
 
 
(1,879
)
   
1,211
     
-
 
Interest income not taxable in the U.S.
 
 
(525
)
   
(1,243
)    
(1,649
)
Change in valuation allowance
 
 
(2,219
   
480
     
3,317
 
Tax impact of special charges, net
 
 
173
 
   
1,678
     
11,773
 
Research & Development tax credit
 
 
(2,291
)
   
(71
   
(16
)
Section 199 Manufacturing Deduction
 
 
(1,658
)
   
(2,036
)    
(757
)
Other
 
 
968
 
   
2,199
     
(86
)
Total
 
$
50,436
 
  $
55,855
    $
34,348
 
 
Deferred income tax balances at each year-end related to:
 
2016
 
 
2015
 
Deferred Tax Assets:
               
Employee benefit costs
 
$
46,249
 
  $
50,679
 
Foreign tax credit carryforward
 
 
11,593
 
   
11,621
 
Tax loss carryforwards
 
 
19,902
 
   
21,090
 
Other
 
 
20,612
 
   
24,373
 
Gross Deferred Tax Assets
 
 
98,356
 
   
107,763
 
Less: Valuation Allowance
 
 
(11,929
)
   
(14,393
)
Total Net Deferred Tax Assets
 
 
86,427
 
   
93,370
 
Deferred Tax Liability:
               
Depreciation and amortization
 
 
(66,589
)
   
(61,992
)
Total Deferred Tax Liability
 
 
(66,589
)
   
(61,992
)
Net Deferred Tax Assets
 
$
19,838
 
  $
31,378
 
 
The difference between the change in the deferred tax assets in the balance sheet and the deferred tax provision is primarily due to the defined benefit pension plan adjustment recorded in accumulated other comprehensive income (loss).
 
In
November
2015,
the FASB issued ASU No.
2015
-
17,
 
Income Taxes (Topic
740):
Balance Sheet Classification of Deferred Taxes
, which amends the guidance requiring companies to separate deferred income tax liabilities and assets into current and non-current amounts in a classified statement of financial position. This accounting guidance simplifies the presentation of deferred income taxes, such that deferred tax liabilities and assets be classified as non-current in a classified statement of financial position. This accounting guidance is effective for us beginning in the
first
quarter of
2018,
but we have elected to adopt this guidance prospectively as of 
November
28,
2015.
  As a result we have classified all deferred tax liabilities and assets as non-current in the Consolidated Balance Sheet at
December
3,
2016.
 
Valuation allowances principally relate to foreign net operating loss carryforwards where the future potential benefits do not meet the more-likely-than-not realization test. The decrease in the valuation allowance of
$2,464
during
2016
is due primarily to the release of the valuation allowance of H.B. Fuller (Nanjing) Chemical Co., Ltd. and of H.B. Fuller India Adhesives Private Limited.
 
Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those deferred tax assets and liabilities are expected to be realized or settled. We record a valuation allowance to reduce deferred tax assets to the amount that is believed more-likely-than-not to be realized. We believe it is more-likely-than-not that carryback potential, reversal of deferred tax liabilities and forecasted income, will be sufficient to fully recover the net deferred tax assets not already offset by a valuation allowance. In the event that all or part of the gross deferred tax assets are determined not to be realizable in the future, an adjustment to the valuation allowance would be charged to earnings in the period such determination is made.
 
 
U.S. income taxes have not been provided on approximately
$434,430
of undistributed earnings of non-U.S. subsidiaries. We intend to indefinitely reinvest these undistributed earnings. Cash available in the United States has historically been sufficient and we expect it will continue to be sufficient to fund U.S. cash flow requirements. In the event these earnings are later distributed to the U.S., such distributions would likely result in additional U.S. tax that
may
be offset, at least in part, by associated foreign tax credits.
 
While non-U.S. operations have been profitable overall, there are cumulative tax losses of
$99,021
in various countries. These tax losses can be carried forward to offset the income tax liabilities on future income in these countries. Cumulative tax losses of
$53,938
can be carried forward indefinitely, while the remaining
$45,083
of tax losses must be utilized during
2016
to
2025.
 
The U.S. has a foreign tax credit carryforward of
$11,593
which will expire in
2022
and
2023.
Projected foreign source income in future years is sufficient to utilize these credits in the carryforward period.
 
The table below sets forth the changes to our gross unrecognized tax benefit as a result of uncertain tax positions, excluding accrued interest, for the fiscal years ended
December
3,
2016
and
November
28,
2015.
  We do not anticipate that the total unrecognized tax benefits will change significantly within the next
twelve
months.
 
 
 
2016
 
 
2015
 
Balance at beginning of year
 
$
4,870
 
  $
4,787
 
Tax positions related to the current year:
               
Additions
 
 
774
 
   
877
 
                 
Tax positions related to prior years:
               
Additions
 
 
209
 
   
439
 
Reductions
 
 
(377
)
   
(557
)
Settlements
 
 
(131
)
   
-
 
Lapses in applicable statutes of limitation
 
 
(1,180
)
   
(676
)
Balance at end of year
 
$
4,165
 
  $
4,870
 
 
Included in the balance of unrecognized tax benefits as of
December
3,
2016,
are potential benefits of
$3,735
that, if recognized, would affect the effective tax rate.
 
We report accrued interest and penalties related to unrecognized tax benefits in income tax expense. For the year ended
December
3,
2016,
we recognized a net benefit for interest and penalties of
$87
relating to unrecognized tax benefits and had net accumulated accrued interest and penalties of
$676
as of
December
3,
2016.
For the year ended
November
28,
2015,
we recognized a net benefit for interest and penalties of
$179
relating to unrecognized tax benefits and had net accumulated accrued interest and penalties of
$631
as of
November
28,
2015.
 
We are subject to U.S. federal income tax as well as income tax in numerous state and foreign jurisdictions. We are no longer subject to U.S. federal tax examination for years prior to
2011
or Swiss income tax examination for years prior to
2009.
During
2015,
the U.S. tax authorities opened an audit for the years ended
December
1,
2012
and
November
30,
2013.
During the
first
quarter of
2015,
the Swiss tax authorities opened an audit for the years ended
December
3,
2011
and
December
1,
2012.
The Swiss audit was closed in the
second
quarter of
2015
with no assessment. During the
second
quarter of
2016,
H.B. Fuller (China) Adhesives, Ltd. was notified of a transfer pricing audit covering the calendar years
2005
through
2014.
We are in various stages of examination and appeal in several states and other foreign jurisdictions. Although the final outcomes of these examinations cannot currently be determined, we believe that we have recorded adequate liabilities with respect to these examinations.